RxDoctor Payments Data

Angelique Berens, MD

Otolaryngology/Facial Plastic Surgery · Marysville, WANPI 1861768582

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (52.9%), travel and lodging and other — rather than concentrated in one kind of arrangement. Medtronic accounts for 67.0% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2023 at $2,989 and has fallen 99.1% since, to $26 in 2025.

$3,860in general payments, 2019–2025

Across 30 payments — averaging $128.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Intersect ENT, Inc.$371
  • Integra Lifesciences Corporation$330
  • Stryker$301
  • Musculoskeletal Transplant Foundation Inc.$270

What the payments were for

  • Travel & lodging$1,48939%
  • Food & beverage$2,04153%
  • Other$3309%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otolaryngology/facial plastic surgery providers in Washingtonto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$115,155
Medicare patients
198
Services billed
1,412

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl237$5,508
Ipratropium Bromide90$2,682
Mupirocin202$2,615
Omeprazole58$1,352
Triamcinolone Acetonide11$1,115
Cephalexin51$429
Azithromycin51$282
Methylprednisolone35$277
Oxycodone Hcl58$201
ErythromycinErythromycin Base16$161
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$152
Ondansetron Hcl38$151
Pantoprazole Sodium15$135
Prednisone23$66
Ondansetron OdtOndansetron11$57

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Marysville

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →